Poilpot S, Sebastien C, Buffet M, Akker M V, Kujas A, Villet R
Service de Chirurgie Viscérale et Gynécologique.
J Gynecol Obstet Biol Reprod (Paris). 2000 Apr;29(2):142-7.
Today, the widespead use of mammography has increased the detection of suspected nonpalpable lesions. Accordingly, the number of surgical biopsies is higher.
Evaluation of Advanced Breast Biopsy Instrumentation (ABBI) system as a promising alternative to conventional surgical biopsy in stereotactic excisional breast biopsies less than 20 mm.
From October 1998 and May 1999, 33 women have had: stereotactic excisional breast biopsies less than 20mm using ABBI. Epidemiologic, mammographic and histologic datas were collected.
Mammographic finding were 23 microcalcifications and 10 nonpalpable solid nodular densities. In 25 cases, pathology were benign (79%), 7 cases (21%) were cancer. In these cases, the cancer could be treated later, with a single surgical procedure. No complication occurred and tolerance was excellent in most cases.
Stereotactic excisional breast biopsies less than 20 mm using ABBI is a very good alternative (reliable, reproducible, ambulatory, very weak morbidity) to surgical biopsy.
如今，乳腺钼靶检查的广泛应用增加了对可疑不可触及病变的检测。相应地，手术活检的数量也更高。
评估先进乳腺活检仪器（ABBI）系统，作为小于20毫米的立体定向切除乳腺活检中传统手术活检的一种有前景的替代方法。
从1998年10月至1999年5月，33名女性接受了：使用ABBI进行小于20毫米的立体定向切除乳腺活检。收集了流行病学、乳腺钼靶和组织学数据。
乳腺钼靶检查发现23处微钙化和10处不可触及的实性结节密度。25例病理结果为良性（79%），7例（21%）为癌症。在这些病例中，癌症可稍后通过单一手术程序进行治疗。未发生并发症，大多数情况下耐受性良好。
使用ABBI进行小于20毫米的立体定向切除乳腺活检是手术活检的一种非常好的替代方法（可靠、可重复、门诊可做、发病率极低）。
